Back to venturesActive
BR
Biosite Research
2024
Keeping Pace with Every Evolving Cell
Pharmaceutical ResearchStatistical AnalysisRegulatory Intelligence
Total Raised
Bootstrapped
Team
50+
Revenue
Profitable
Exit Value
—
Overview
Started in 2016, we conduct Clinical Trials of new/novel therapies, while maintaining elevated levels of Data Confidentiality & Regulatory Compliance. 70+ trials conducted till date.
The Target
Scale to IPO by 2035